Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
50 participants
INTERVENTIONAL
2013-08-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TEAM: Trial of Early Activity and Mobilization
NCT01674608
The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
NCT05298982
Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation
NCT03133377
Extracorporeal Membrane Oxygenation Physical Training
NCT03328767
Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units
NCT06700694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
early mobilisation
intervention of early mobilisation
Early mobilisation
Control
Standard care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early mobilisation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Invasively ventilated and expected to be ventilated the day after tomorrow
* Written informed consent from person responsible/ net of kin (or consent as per individual HREC if delayed or telephone consent is acceptable)
Exclusion Criteria
* Unresolved rhythm disturbance with any bradycardia requiring pharmacological support
* Any tachycardia with ventricular rate \> 150 beats/min
* Lactacte \> 4.0 due to inadequate tissue perfusion
* Any external mechanical cardiovascular support (eg. VA ECMO or intra-aortic balloon pump)
* Norad \> 0.2mcg/kg/min (or unit equivalent) or any dose of norad between 0.1 and 0.2mcg/kg/min with more than a 25% increase in last 6 hours
* Cardiac index \< 2.0L/min/m\^2
B. Respiratory
* FiO2 \> 0.6
* PEEP \> 15
* Requirement for hypoxaemic rescue interventions eg. NO, prone, ECMO, prostacyclin, HFOV
* RR \> 45
2. Proven or suspected actue brain injury such as stroke, sub-arachnoid haemorrhage, encephalitis, or moderate to severe traumatic brain injury
3. Proven or suspected actue spinal cord injury
4. Proven or suspected Guillain-Barre Syndrome
5. Second or subsequent ICU admission during a single hospital admission
6. Unable to follow simple verbal commands in English
7. Death inevitable and imminent
8. Inability to walk without assistance of another person prior to onset of acute illness necessitating ICU admission
9. Cognitive impairment prior to current acute illness
10. Agitation which int he opinion of the treating clinician precludes safe implementation of EGDM
11. Written rest in bed orders due to documented injury or process the precludes mobilisation such as suspected or proven instability of spine or pelvis
12. In the opinion of the treating clinician it is unsafe to commence EGDM
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Australian and New Zealand Intensive Care Society Clinical Trials Group
NETWORK
Australian and New Zealand Intensive Care Research Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carol L Hodgson, PhD
Role: STUDY_CHAIR
Australian and New Zealand Intensive Care Research Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Austin Hospital
Heidelberg, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Fremantle Hospital
Fremantle, Western Australia, Australia
Auckland CIty Hospital CVICU
Grafton, Auckland, New Zealand
Wellington Hospital
Newtown, Wellington Region, New Zealand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hodgson CL, Bailey M, Bellomo R, Berney S, Buhr H, Denehy L, Gabbe B, Harrold M, Higgins A, Iwashyna TJ, Papworth R, Parke R, Patman S, Presneill J, Saxena M, Skinner E, Tipping C, Young P, Webb S; Trial of Early Activity and Mobilization Study Investigators. A Binational Multicenter Pilot Feasibility Randomized Controlled Trial of Early Goal-Directed Mobilization in the ICU. Crit Care Med. 2016 Jun;44(6):1145-52. doi: 10.1097/CCM.0000000000001643.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT01927510
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.